GREENSBORO, N.C. - After upholding the validity of a patent on the eyelash-growth drug Latisse, a North Carolina federal judge on April 23 enjoined four defendants from marketing and selling a generic equivalent (Allergan Inc. v. Apotex Inc., et al., Nos. 10-681, 11-298, 11-650 and 11-321, M.D. N.C.)....(read more)Image may be NSFW.
Clik here to view.
Clik here to view.
